Recently, a member of the small leucine-rich repeat proteoglycan (SLRP) family, named biglycan (BGN), has been shown as a regulator of MHC class I expression in HER‐2/neu- [18, 19] and K-RAS- [20] transformed cancer cells. Here, BGN is linked to cancer.